Ipriflavone: Difference between revisions

	WikiDoc Resources for Ipriflavone
Articles
Most recent articles on Ipriflavone Most cited articles on Ipriflavone Review articles on Ipriflavone Articles on Ipriflavone in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Ipriflavone Images of Ipriflavone Photos of Ipriflavone Podcasts & MP3s on Ipriflavone Videos on Ipriflavone
Evidence Based Medicine
Cochrane Collaboration on Ipriflavone Bandolier on Ipriflavone TRIP on Ipriflavone
Clinical Trials
Ongoing Trials on Ipriflavone at Clinical Trials.gov Trial results on Ipriflavone Clinical Trials on Ipriflavone at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Ipriflavone NICE Guidance on Ipriflavone NHS PRODIGY Guidance FDA on Ipriflavone CDC on Ipriflavone
Books
Books on Ipriflavone
News
Ipriflavone in the news Be alerted to news on Ipriflavone News trends on Ipriflavone
Commentary
Blogs on Ipriflavone
Definitions
Definitions of Ipriflavone
Patient Resources / Community
Patient resources on Ipriflavone Discussion groups on Ipriflavone Patient Handouts on Ipriflavone Directions to Hospitals Treating Ipriflavone Risk calculators and risk factors for Ipriflavone
Healthcare Provider Resources
Symptoms of Ipriflavone Causes & Risk Factors for Ipriflavone Diagnostic studies for Ipriflavone Treatment of Ipriflavone
Continuing Medical Education (CME)
CME Programs on Ipriflavone
International
Ipriflavone en Espanol Ipriflavone en Francais
Business
Ipriflavone in the Marketplace Patents on Ipriflavone
Experimental / Informatics
List of terms related to Ipriflavone

Ipriflavone
Clinical data
Synonyms	3-phenyl-7-propan-2-yloxychromen-4-one
AHFS/Drugs.com	International Drug Names
ATC code	M05BX01 (WHO) ;
Identifiers
	IUPAC name 7-isopropoxy-3-phenyl-4H-chromen-4-one;
CAS Number	35212-22-7 ;
PubChem CID	3747;
ChemSpider	3616 ;
UNII	80BJ7WN25Z;
KEGG	D01338 ;
ChEMBL	ChEMBL165790 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C18H16O3
Molar mass	280.318 g/mol
3D model (JSmol)	Interactive image;
	SMILES CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3;
	InChI InChI=1S/C18H16O3/c1-12(2)21-14-8-9-15-17(10-14)20-11-16(18(15)19)13-6-4-3-5-7-13/h3-12H,1-2H3 ; Key:SFBODOKJTYAUCM-UHFFFAOYSA-N ;
(what is this?) (verify)

← Older edit

Latest revision as of 16:32, 20 August 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ipriflavone is a synthetic isoflavone which may be used to inhibit bone resorption,^[1] maintain bone density and to prevent osteoporosis in postmenopausal women. It is not used to treat osteoporosis. It slows down the action of the osteoclasts (bone-eroding cells), possibly allowing the osteoblasts (bone-building cells) to build up bone mass.

A clinical trial reported in 2001 that it was not effective in prevention or treatment of osteoporosis.^[2]

A double-blind study reveals that ipriflavone might be effective on reducing tinnitus on otosclerosis sufferers.^[3]

References

↑ Civitelli, R. (1997). "In Vitro and in Vivo effects of ipriflavone on bone formation and bone biomechanics". Calcified Tissue International. 61: S12–4. doi:10.1007/s002239900378. PMID 9263610.
↑ Alexandersen, P.; Toussaint, A; Christiansen, C; Devogelaer, JP; Roux, C; Fechtenbaum, J; Gennari, C; Reginster, JY; Ipriflavone Multicenter European Fracture Study (2001). "Ipriflavone in the Treatment of Postmenopausal Osteoporosis: A Randomized Controlled Trial". JAMA. 285 (11): 1482–8. doi:10.1001/jama.285.11.1482. PMID 11255425.
↑ Sziklai, I; Komora, V; Ribári, O (1992). "Double-blind study on the effectiveness of a bioflavonoid in the control of tinnitus in otosclerosis". Acta chirurgica Hungarica. 33 (1–2): 101–7. PMID 1343452.

External links

Ipriflavone at PDR Health

Template:Drugs for treatment of bone diseases

[pmid9263610-1] Civitelli, R. (1997). "In Vitro and in Vivo effects of ipriflavone on bone formation and bone biomechanics". Calcified Tissue International. 61: S12–4. doi:10.1007/s002239900378. PMID 9263610.

[2] Alexandersen, P.; Toussaint, A; Christiansen, C; Devogelaer, JP; Roux, C; Fechtenbaum, J; Gennari, C; Reginster, JY; Ipriflavone Multicenter European Fracture Study (2001). "Ipriflavone in the Treatment of Postmenopausal Osteoporosis: A Randomized Controlled Trial". JAMA. 285 (11): 1482–8. doi:10.1001/jama.285.11.1482. PMID 11255425.

[3] Sziklai, I; Komora, V; Ribári, O (1992). "Double-blind study on the effectiveness of a bioflavonoid in the control of tinnitus in otosclerosis". Acta chirurgica Hungarica. 33 (1–2): 101–7. PMID 1343452.

[1]

[2]

[3]

Revision as of 13:16, 13 April 2015 view source Turky Alkathery (talk \| contribs) CMEUser, nocaptcha, Administrators 6,562 edits No edit summary ← Older edit	Latest revision as of 16:32, 20 August 2015 view source WikiBot (talk \| contribs) Bots, Bureaucrats, bureaucrats, interwiki, nocaptcha, Administrators 57,550 edits m Protected "Ipriflavone": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))
(No difference)

Ipriflavone: Difference between revisions

Latest revision as of 16:32, 20 August 2015

Overview

References

External links

Navigation menu

Search